Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.
Published
Journal Article
Clinical management of infective endocarditis (IE) is expected to become more difficult with the emergence of Staphylococcus aureus with reduced susceptibility to vancomycin (SARV) in the United States and worldwide. We report the strain characterization and treatment of a patient with SARV IE.
Full Text
Duke Authors
- Fowler Jr., Vance Garrison
- Ginsburg, Geoffrey Steven
- Wilson, Kenneth Heaton
- Woods, Christopher Wildrick
Cited Authors
- Woods, CW; Cheng, AC; Fowler, VG; Moorefield, M; Frederick, J; Sakoulas, G; Meka, VG; Tenover, FC; Zwadyk, P; Wilson, KH
Published Date
- April 15, 2004
Published In
- Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Volume / Issue
- 38 / 8
Start / End Page
- 1188 - 1191
PubMed ID
- 15095227
Pubmed Central ID
- 15095227
Electronic International Standard Serial Number (EISSN)
- 1537-6591
Digital Object Identifier (DOI)
- 10.1086/383027
Language
- eng
Conference Location
- United States